worldwiki
サービス · Stem Cell

Cell Banking

別名: Cell Banking, SVFバンキング, セルバンク, 細胞保管サービス, 셀뱅킹

公開 2026年9月14日更新 2026年11月12日
本サイトのサーバーログに記録されたリクエストです。クローラーの身元は逆引きDNSまたはIP範囲で確認しています。Meta127OpenAI112Google40Ahrefs6Microsoft6Perplexity3Parallel2Yandex2Anthropic1Apple1初回収集 2026年9月15日最近のリクエストOpenAI2026年11月12日OpenAI2026年11月11日OpenAI2026年11月10日OpenAI2026年11月9日OpenAI2026年11月9日OpenAI2026年11月8日OpenAI2026年11月8日OpenAI2026年11月7日OpenAI2026年11月6日OpenAI2026年11月6日OpenAI2026年11月5日OpenAI2026年11月4日
訂正を依頼
言語Englishこの言語にはまだ翻訳されていないため、英語の原文を表示しています。
定義

Cell banking is a service that isolates and cryopreserves a person's own cells, such as adipose SVF, for possible future use.

クイック回答

제대혈 줄기세포는 성체줄기세포인가요? 어디에 쓰이나요?

제대혈 줄기세포는 출산 때 탯줄과 태반에 남은 혈액에서 얻는 줄기세포입니다. 배아줄기세포가 아니라는 점에서 넓게는 성체(체성)줄기세포에 넣고, 출생 시점에 얻는다는 뜻에서 주산기 줄기세포로 따로 부르기도 합니다. 주성분은 혈액을 만드는 조혈모세포이며, 미국 FDA가 허가한 용도도 백혈병 등 조혈계 질환의 이식에 한정됩니다.

検証済み 2026年10月8日

主要な事実

項目値出典
Private vs public bankingPrivate banks store cord blood for the child donor or first- or second-degree relatives. Public banks store donated units for unrelated patients.時点 2018年3月23日[3]governmentCord Blood Banking - Information for ConsumersU.S. Food and Drug Administration
US regulation of private cord blood banksMust register with the FDA and follow donor screening, infectious disease testing and current good tissue practice rules. Cord blood for personal or close-relative use does not need approval before use.時点 2018年3月23日[3]governmentCord Blood Banking - Information for ConsumersU.S. Food and Drug Administration
Meaning of FDA registrationRegistration only confirms that the facility notified the FDA of its operations. It is not an endorsement.時点 2018年3月23日[3]governmentCord Blood Banking - Information for ConsumersU.S. Food and Drug Administration
FDA-approved stem cell productsOnly cord blood-derived blood-forming stem cells for disorders of blood production. Adipose-derived and other products are not approved for orthopedic, neurological, cardiovascular or other conditions.時点 2024年4月9日[4]governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and ExosomesU.S. Food and Drug Administration
Korea: family cord blood bank licenceUnder the Act on Cord Blood Management and Research, a family cord blood bank needs a licence from the Minister of Health and Welfare and must meet facility, equipment, staffing and quality-management requirements.時点 2011年7月1日[5]other제대혈 관리 및 연구에 관한 법률 (Act on Cord Blood Management and Research, Law No. 10130)Wikisource (Korean) – statutory text
Korea: cell processing facility approvalCell processing requires MFDS approval as an advanced regenerative medicine cell processing facility, and the licence must be renewed every 3 years (Advanced Regenerative Bio Act, Art. 15).時点 2020年8月28日[6]other첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률 제15조(첨단재생의료세포처리시설)CaseNote (법령 원문)
Korea 2025 amendmentTook effect 2025-02-21. It added a treatment track that needs committee approval of each plan. Institutions that supply patient-derived cells after only minimal manipulation (isolation, washing, freezing, thawing) are treated as licensed.時点 2025年2月21日[7]industry첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률의 개정 및 시행과 그 시사점법무법인(유) 세종
Evidence on cryopreserved SVFA systematic review (studies 2008–2025) found post-thaw SVF viability broadly comparable to fresh tissue. It said standardized protocols and functional potency assays are still needed.時点 2026年8月1日[8]journalEffects of Cryopreservation on Stromal Vascular Fraction Viability in Human Adipose Tissue: Insights from a Systematic Review (Farhana S et al., Tissue Eng Regen Med, DOI 10.1007/s13770-026-00833-1)Europe PMC / Tissue Engineering and Regenerative Medicine (Springer Nature)
Factors affecting SVF qualityLonger freezing periods and longer enzymatic digestion reduced viability, and storage temperature itself had little effect. Short-term storage (<1 month) with cryoprotectants such as DMSO or trehalose was associated with the best preservation.時点 2026年8月1日[8]journalEffects of Cryopreservation on Stromal Vascular Fraction Viability in Human Adipose Tissue: Insights from a Systematic Review (Farhana S et al., Tissue Eng Regen Med, DOI 10.1007/s13770-026-00833-1)Europe PMC / Tissue Engineering and Regenerative Medicine (Springer Nature)
Public cord blood collections not stored85–90% of collected samples are not stored, because public banks prioritize larger units (as reported in a review) %時点 2024年10月7日[9]journalCord blood banking: Balancing hype and hope in stem cell therapyEuropean Journal of Midwifery (via PubMed Central)
Storage temperatureLiquid nitrogen, about −196 °C[1]governmentNCI Dictionary of Cancer Terms: cryopreservationNational Cancer Institute (NCI)
What to checkApproved future use, viability testing after thaw, facility licensing, contract terms and fees[2]organizationAbout Stem Cells — patient resourceInternational Society for Stem Cell Research

概要

Cell banking (셀뱅킹) is a service that cryopreserves a person's own cells or tissue, such as umbilical cord blood or adipose-derived stromal vascular fraction (SVF), for possible later use. Private (family) banks store cells for the donor or relatives for a fee, while public banks hold donated cord blood for unrelated patients. In the US, private cord blood banks must register with the FDA and follow donor-testing and tissue-practice rules. Registration does not mean the FDA endorses the bank. The only FDA-approved stem cell products are cord blood-derived blood-forming cells for blood disorders. In Korea, family cord blood banks need a health ministry licence, and cell processing needs MFDS approval. Studies report that the quality of frozen SVF varies with processing and storage time. Readers should check the bank's licences and which regulated uses actually exist.

検証済みプロバイダー

有料掲載は明示されます。検証は支払いと無関係です。
検証済み

SC301의원

SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, lifting and cell banking as its main services.

プロバイダーを見る

参考文献

独立出典比率 89% (8/9)
レベル A · 3レベル B · 2レベル C · 2レベル D · 1レベル E · 1
  1. レベル A · governmentNCI Dictionary of Cancer Terms: cryopreservation — National Cancer Institute (NCI) · 閲覧日 2026年11月12日 · 根拠ページ
  2. レベル C · organizationAbout Stem Cells — patient resource — International Society for Stem Cell Research · 閲覧日 2026年11月12日 · 根拠ページ
  3. レベル A · governmentCord Blood Banking - Information for Consumers — U.S. Food and Drug Administration · 閲覧日 2026年11月10日 · 根拠ページ
  4. レベル A · governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — U.S. Food and Drug Administration · 閲覧日 2026年11月12日 · 根拠ページ
  5. レベル E · other제대혈 관리 및 연구에 관한 법률 (Act on Cord Blood Management and Research, Law No. 10130) — Wikisource (Korean) – statutory text · 閲覧日 2026年11月10日 · 根拠ページ
  6. レベル C · other첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률 제15조(첨단재생의료세포처리시설) — CaseNote (법령 원문) · 閲覧日 2026年11月10日 · 根拠ページ
  7. レベル D · industry첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률의 개정 및 시행과 그 시사점 — 법무법인(유) 세종 · 閲覧日 2026年11月10日 · 根拠ページ
  8. レベル B · journalEffects of Cryopreservation on Stromal Vascular Fraction Viability in Human Adipose Tissue: Insights from a Systematic Review (Farhana S et al., Tissue Eng Regen Med, DOI 10.1007/s13770-026-00833-1) — Europe PMC / Tissue Engineering and Regenerative Medicine (Springer Nature) · 閲覧日 2026年11月12日 · 根拠ページ
  9. レベル B · journalCord blood banking: Balancing hype and hope in stem cell therapy — European Journal of Midwifery (via PubMed Central) · 閲覧日 2026年11月11日 · 根拠ページ
変更履歴
初回公開 · 2026年9月14日